Clinical Trial Update: Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing riluzole as a symptomatic treatment for chronic cerebellar ataxia has completed, evaluating individuals with hereditary ataxia and mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebellar Ataxia
• Hereditary Ataxia
• Multiple Sclerosis

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: S. Andrea Hospital | Conditions: Hereditary Ataxia, Multiple Sclerosis | Phase 2 | Status: COMPLETED